Atlantic Canada includes Newfoundland and Labrador!

Here in Atlantic Canada, we have an incredible community of volunteers, donors and sponsors, as well as an innovative team of researchers and healthcare professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved! Every volunteer, donor, researcher and sponsor helps us to improve the lives of those affected by Crohn’s disease and ulcerative colitis, and brings us closer to finding cures.

We welcome newcomers – contact us today and, together, we’ll make it stop. For life.

Katherine Digby
Regional Director, Quebec & Atlantic Provinces
kdigby@crohnsandcolitis.ca

Karen Lacey
Development Coordinator, Newfoundland & Labrador 

Karen Lacey

2021 Galas for Crohn’s and Colitis Canada

2021 Galas for Crohn’s and Colitis Canada

Gala season is here! Are you ready to celebrate all that Crohn’s and Colitis Canada has accomplished with your generous support?  This year, with the help of our amazing Gala community ...

 • 
From the comfort of your home
 • 
post it note with a light bulb

Virtual Focus Groups

Call for input for important research on improving access to IBD care. If you live with Crohn’s disease or ulcerative colitis, and are over 18 years old, we are interested in hearing from ...

 • 
Canada
 • 
Remember to bookmark this page.

St. John's Office

PO Box 39093
St. John's, NL, A1E 5Y7

(709) 743-5142 or 1-844-299-4517

Search by Postal Code

News

Crohn’s and Colitis Canada, MS Society of Canada – Ottawa Chapter and the GottaGo! Campaign partner to improve washroom access

Crohn’s and Colitis Canada, MS Society of Canada – Ottawa Chapter and the GottaGo! Campaign partner to improve washroom access

Joint Statement from the Canadian Association of Gastroenterology and Crohn’s and Colitis Canada

Joint Statement from the Canadian Association of Gastroenterology and Crohn’s and Colitis Canada

Crohn's and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs

Crohn's and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs

 13 14 15 16 17 18 19 20 21 22